Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender, who are willing to sign a consent form agreeing to take part in the study
- People who have been diagnosed with achalasia (a condition affecting the ability to swallow) and have already had a procedure called POEM (a minimally invasive surgery to treat achalasia)
Who may not be able to join:
- People who are unwilling or unable to provide written consent to participate in the study
- People who have health conditions that make it unsafe for them to undergo a camera examination of the throat and stomach, or a test that measures the pressure and movement of the food pipe (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna Chaber-Ciopińska, PhD, The Maria Sklodowska-Curie National Research Institute of Oncology
Phone: (+48) 225463044
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The prevalence of gastroesophageal reflux after peroral endoscopic myotomy (POEM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.